# Long-term Clinical Study of CN128 in Thalassemia With Sever Liver Iron Overloaded Patients

> **NCT05355766** · PHASE2 · COMPLETED · sponsor: **Hangzhou Zede Pharma-Tech Co., Ltd.** · enrollment: 16 (actual)

## Conditions studied

- Thalassemia
- Iron Overload

## Interventions

- **DRUG:** CN128 Tablets

## Key facts

- **NCT ID:** NCT05355766
- **Lead sponsor:** Hangzhou Zede Pharma-Tech Co., Ltd.
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-06-13
- **Primary completion:** 2024-09-23
- **Final completion:** 2025-03-06
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2025-03-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05355766

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05355766, "Long-term Clinical Study of CN128 in Thalassemia With Sever Liver Iron Overloaded Patients". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT05355766. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*